A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast ( Malassezia pachydermatis ) Otitis Externa in Dogs
Veterinary Dermatology · 2026-12 · 37 (6) · 1020-1028
DOI: 10.1111/vde.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, online erschienen am 24.08.2026. Verfasst von Zorica Zivkovic Baks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dechra Veterinary Products BV, Bladel, the Netherlands. Hauptthemen laut MEDLINE: Antifungal Agents, Betamethasone, Dermatomycoses, Dog Diseases. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Otitis externa (OE) with Malassezia pachydermatis overgrowth with limited bacterial involvement is common in dogs. Treatment with products containing antibiotics is unnecessary and not consistent with judicious use of antimicrobials.
Objectives
To evaluate the efficacy and safety of an otic gel containing 1% terbinafine and 0.1% betamethasone acetate for the treatment of yeast‐predominant canine OE. Animals 239 privately owned dogs were enrolled. Materials and Methods Inclusion criteria were an otitis index score (OTIS3) of ≥ 6 and yeast‐predominance on ear swab cytological evaluation. Dogs received either the study product containing terbinafine and betamethasone (TBG) or placebo (saline) on Day (D) 0 and D7. Follow‐up visits were on D7, D14, D28 and D45. Clinical success was defined as an OTIS3 score ≤ 3 on D45. Overall clinical response (by the veterinary surgeon and owner) and yeast cytological count reduction also were assessed. Safety was evaluated based on clinical assessments, haematological and clinical chemical analysis, urinalysis and adverse events.
Results
The treatment success was significantly higher in the treated group compared to the placebo group (62.9% versus 20.0%, p < 0.0001). Dogs receiving TBG had a treatment response described as ‘excellent’ or ‘good’ by 61.9% and 71.1% of veterinary surgeons and owners, respectively. The safety evaluation demonstrated that the otic gel was safe. Conclusions and Clinical Relevance Efficacy and safety of an otic gel for the treatment of canine OE associated with Malassezia pachydermatis were demonstrated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dechra Veterinary Products BV, Bladel, the Netherlands.
- Dechra Development LLC, Boston, Massachusetts, USA.
- Dechra Veterinary Products Deutschland GmbH, Aulendorf, Germany.
- Vista Research, LLC, Bath, Maine, USA.
ORCID-Profile: Hope Baird Heinz
Zitieren
APA
Baks, Z. Z., Heinz, H. B., Grundke, S., Thompson, C., & Garcia, R. (2026). A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast ( Malassezia pachydermatis ) Otitis Externa in Dogs. Veterinary Dermatology, 37(6), 1020-1028. https://doi.org/10.1111/vde.70113
Vancouver
Baks ZZ, Heinz HB, Grundke S, Thompson C, Garcia R. A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast ( Malassezia pachydermatis ) Otitis Externa in Dogs. Veterinary Dermatology. 2026;37(6):1020-1028. doi:10.1111/vde.70113
BibTeX
@article{Baks2026,
author = {Baks, Zorica Zivkovic and Heinz, Hope Baird and Grundke, Stephan and Thompson, Caryn and Garcia, Roberto},
title = {A Randomised Placebo‐Controlled Study to Evaluate the Efficacy and Safety of a Two‐Dose Topical Terbinafine and Betamethasone Gel for the Treatment of Yeast ( Malassezia pachydermatis ) Otitis Externa in Dogs},
journal = {Veterinary Dermatology},
year = {2026},
volume = {37},
number = {6},
pages = {1020--1028},
doi = {10.1111/vde.70113}
}
EUVIMED